Follow-up Management of Hodgkin Lymphoma Survivors

PROGRAM CE11
RELEASE DATE: APRIL 15, 2011   EXPIRATION DATE: APRIL 15, 2012
ESTIMATED TIME TO COMPLETE: 1.0 HOUR
Click here to complete the posttest and obtain a CE certificate online
Download PDF

STATEMENT OF NEED
Hodgkin lymphoma is a highly curable cancer that is most common in younger adults and children. Long after therapy completion, treatment-related toxicities are often evident and second malignancies can arise. Follow-up care for patients in remission involves monitoring them for recurrent disease and managing existing and emergent treatment-induced adverse effects. Although current guidelines outline appropriate surveillance measures for detecting recurrence and second malignancies, limited data are available on the quality of follow-up care being provided to survivors of Hodgkin lymphoma.

TARGET AUDIENCE
Advanced practice nurses, registered nurses, and other interested healthcare professionals, especially those caring for cancer patients

LEARNING OBJECTIVES
After completing this activity, the reader should be able to:
  Recognize the need for long-term follow-up to detect and manage delayed effects of treatment and second malignancies in patients with Hodgkin lymphoma.
Incorporate recommended interventions into practice for screening Hodgkin lymphoma survivors for cancer.

 CONTINUING NURSING EDUCATION ACCREDITATION AND CONTACT HOURS STATEMENT
Science Care is approved by the California Board of Registered Nursing, Provider number 15559, for 1.0 Contact hour.

METHOD OF PARTICIPATION

1. Read the article in its entirety
2. Select “Click here to complete the posttest and obtain a CE certificate online”
3. Complete and submit the CE posttest and CE Activity Evaluation
4. Print your Certificate of Credit This activity is provided free of charge to participants.

FACULTY DISCLOSURES
As a provider accredited by the California Board of Registered Nursing, Science Care must ensure balance, independence, objectivity, and scientific rigor in all its activities. All course directors, faculty, planners, and any other individual in a position to control the content of this educational activity are required to disclose to the audience any relevant financial relationships with any commercial interest. Science Care must determine if the faculty’s relationships may influence the educational content with regard to exposition or conclusion and resolve any conflicts of interest prior to the commencement of the educational activity.
Disclosures are as follows:

• David C. Hodgson, MD, MPH, has nothing to disclose.
• Dawn Lagrosa has nothing to disclose.
• Chistina A. Liebertz, APN, RN, has nothing to disclose.
• Christin Melton has nothing to disclose.
• Karen Rosenberg has nothing to disclose.

The staff of Science Care have nothing to disclose.

DISCLAIMER
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of Science Care or Green Hill Healthcare Communications, LLC.

COPYRIGHT STATEMENT
Copyright © 2011 Science Care. All rights reserved.

EDITORIAL BOARD
David C. Hodgson, MD, MPH
Princess Margaret Hospital/
University Health Network
610 University Avenue
Toronto, ON M5G 2M9
Canada

Christina A. Liebertz, APN, RN
Urology Outpatient Center
Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York, NY 10065